Apotex Health Corp. (TSX:APTX)
Canada · Delayed Price · Currency is CAD 37.19
-0.19 (-0.51%)
At close: Aug 10, 2026
Apotex Health Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Apotex Health stock has a consensus rating of "Buy" and an average price target of $41.24. The average 1-year stock price forecast is 10.89% higher than the current stock price, while the lowest is $40.00 (+7.56%) and the highest is $44.30 (+19.12%).
Price Target: $41.24 (+10.89%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Apotex Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $35.91 → $42.00 | Buy | Maintains | $35.91 → $42.00 | +12.93% | Jul 22, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +7.56% | Jul 22, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $42.00 | Buy | Initiates | $42.00 | +12.93% | Jul 13, 2026 |
| Raymond James | Raymond James | Buy Initiates $36.00 | Buy | Initiates | $36.00 | -3.20% | Jul 6, 2026 |
| National Bank | National Bank | Buy Initiates $43.00 | Buy | Initiates | $43.00 | +15.62% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
3.39B
from 3.49B
Decreased by -2.86%
Revenue Next Year
3.69B
from 3.39B
Increased by 8.70%
EPS This Year
2.00
EPS Next Year
2.32
from 2.00
Increased by 16.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.